Bioventus (BVS) EBT Growth (1y) (2021 - 2026)
Bioventus (BVS) EBT Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.54 Bn | 176.24 Bn | 6.27 Bn | -18.50% |
| 2 | Stryker | 129.03 Bn | 126.15 Bn | 3.81 Bn | 11.26% |
| 3 | Medtronic | 108.43 Bn | 99.21 Bn | 6.41 Bn | 45.44% |
| 4 | Boston Scientific | 68.74 Bn | 67.28 Bn | 3.61 Bn | 44.35% |
| 5 | Edwards Lifesciences | 48.34 Bn | 44.67 Bn | 1.29 Bn | 5.78% |
| 6 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | 74.66% |
| 7 | GE HealthCare Technologies | 28.07 Bn | 25.78 Bn | 1.98 Bn | -27.02% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 103.34% |
| 10 | Bioventus | 824.72 Mn | 788.87 Mn | 90.77 Mn | 232.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 232.19% |
| Dec 31, 2025 | 26,784.91% |
| Sep 27, 2025 | 188.80% |
| Jun 28, 2025 | 124.82% |
| Mar 29, 2025 | 37.58% |
| Dec 31, 2024 | 99.37% |
| Sep 28, 2024 | 35.80% |
| Jun 29, 2024 | -855.31% |
| Mar 30, 2024 | 94.53% |
| Dec 31, 2023 | 74.09% |
| Sep 30, 2023 | 93.73% |
| Jul 1, 2023 | 32.97% |
| Apr 1, 2023 | -412.69% |
| Dec 31, 2022 | -1,079.64% |
| Oct 1, 2022 | -4,043.38% |
| Jul 2, 2022 | 28.41% |
| Apr 2, 2022 | -179.89% |
| Dec 31, 2021 | -187.55% |
| Oct 2, 2021 | -137.79% |
| Jul 3, 2021 | -48.87% |